Please turn JavaScript on

Stevenage Bioscience Catalyst

Want to know the latest news and articles posted on Stevenage Bioscience Catalyst?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: Stevenage Bioscience Catalyst: Empowering Innovation

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.13 / day

Message History

Stevenage Bioscience Catalyst joins o2h Discovery Platinum Partner Programme to strengthen support for early-stage biotech Stevenage Bioscience Catalyst (SBC) has joined the o2h Discovery Platinum Partner Programme, creating a new opportunity for eligible biotech companies within its community to access specialist drug discovery expertise and resources. The new collaboration fu...

Read full story
Statement from Stevenage Bioscience Catalyst on GSK’s continued investment in UK life sciences 9AM BST, Stevenage GSK’s announcement of its continued investment in UK life sciences marks an important moment for the sector. Established in 2012 through a partnership between GSK, the Wellcome Trust and the UK Government, Stevenage Bioscience Catalyst is an independent, not-for-prof...

Read full story
Opening doors to the next generation of young scientists Stevenage Bioscience Catalyst welcomed two local sixth-form students, Grace and Blake, for an immersive five-day Work Experience Programme, offering a rare insight into the breadth of science and innovation taking place across our campus.

Chosen from more than 100 applicants, Grace and Blake secured their places ...


Read full story
Welcome ImmuONE to SBC Seed Works! We’re pleased to welcome ImmuONE to the SBC community, as the company takes additional office space on campus alongside its existing laboratory facilities in Stevenage.

ImmuONE specialises in human-relevant respiratory toxicology, developing advanced in vitro models of the human lung and immune system to help organisations better understand ...


Read full story